Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Medicure (MCUJF) Gross Margin (2016 - 2025)

Medicure has reported Gross Margin over the past 17 years, most recently at 31.57% for Q4 2025.

  • For Q4 2025, Gross Margin fell 2680.0% year-over-year to 31.57%; the TTM value through Dec 2025 reached 40.65%, down 1914.0%, while the annual FY2025 figure was 40.71%, 1903.0% down from the prior year.
  • Gross Margin for Q4 2025 was 31.57% at Medicure, down from 33.99% in the prior quarter.
  • Over five years, Gross Margin peaked at 73.69% in Q3 2022 and troughed at 31.57% in Q4 2025.
  • A 5-year average of 60.02% and a median of 60.36% in 2021 define the central range for Gross Margin.
  • Biggest five-year swings in Gross Margin: surged 4397bps in 2021 and later crashed -2680bps in 2025.
  • Year by year, Gross Margin stood at 55.59% in 2021, then increased by 24bps to 69.03% in 2022, then fell by 0bps to 69.03% in 2023, then fell by -15bps to 58.37% in 2024, then tumbled by -46bps to 31.57% in 2025.
  • Business Quant data shows Gross Margin for MCUJF at 31.57% in Q4 2025, 33.99% in Q3 2025, and 51.51% in Q2 2025.